NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Toll Brothers Q4 Earnings: Revenue Up But Cautious 2026 Outlook Sends Shares Lower

Toll Brothers (TOL) reports mixed Q4 results with revenue beating estimates but lower fiscal 2026 delivery guidance amid soft housing demand and market uncertainty.

Toll Brothers Q4 Earnings: Revenue Up But Cautious 2026 Outlook Sends Shares Lower
Credit: Toll Brothers
Already have an account? Sign in.
12/09/2025 · 6:35 AM
TOL
/ Read more

Feed↓

FDA Cracks Down on Compounded GLP-1 Weight Loss Drugs
Featured/ 02/06/2026 · 5:34 PM

FDA Cracks Down on Compounded GLP-1 Weight Loss Drugs

FDA plans to restrict non-approved compounded GLP-1 drugs sold by Hims & Hers and compounding pharmacies, citing safety concerns and misleading marketing practices.

/ Subscriber only
DraftKings Teams Up With Crypto.com for Expanded Prediction Markets
02/06/2026 · 4:05 PM

DraftKings Teams Up With Crypto.com for Expanded Prediction Markets

DraftKings (DKNG) partners with Crypto.com to expand prediction markets, adding player-specific sports contracts and new categories including politics and entertainment.

/ Subscriber only
Pfizer’s Chantix Move Seen as Positive Signal for Achieve Life Sciences
02/06/2026 · 3:53 PM

Pfizer’s Chantix Move Seen as Positive Signal for Achieve Life Sciences

Analysts say Pfizer listing Chantix on TrumpRx may support Achieve Life Sciences and boost confidence in cytisinicline’s approval prospects.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe